Historical salary details - Mr. Kevin Rakin, Executive Chairman of the Board, Elutia Inc - Ordinary Shares - Class A
Mr. Kevin Rakin is the Executive Chairman of the Board of Elutia Inc - Ordinary Shares - Class A. They also hold 1 other positions in and Quantum-Si Incorporated - Ordinary Shares - Class A.
Mr. Kevin Rakin
Executive Chairman of the Board
-
Gross Remuneration
-
Current Company
Elutia Inc - Ordinary Shares - Class A
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Elutia Inc - Ordinary Shares - Class A | Executive Chairman of the Board | - | - |
| 2024 | Quantum-Si Incorporated - Ordinary Shares - Class A | Director | - | - |
| 2023 | Elutia Inc - Ordinary Shares - Class A | - | 254.6 K | -3.4 % |
| 2023 | Quantum-Si Incorporated - Ordinary Shares - Class A | Director | - | - |
| 2022 | Elutia Inc - Ordinary Shares - Class A | Executive Chairman of the Board | 263.6 K | 66.3 % |
| 2022 | Oramed Pharmaceuticals, Inc | Director | 199.8 K | -40.5 % |
| 2022 | Quantum-Si Incorporated - Warrants (10/06/2026) | Director | 155 K | - |
| 2022 | Quantum-Si Incorporated - Ordinary Shares - Class A | - | 155 K | -32.8 % |
| 2022 | Nyxoah SA | Independent Director | 64.3 K | 114.3 % |
| 2022 | Oramed Pharmaceuticals, Inc | Chairman of the Board | - | - |
| 2021 | Oramed Pharmaceuticals, Inc | Chairman of the Board | 335.8 K | 344.8 % |
| 2021 | Quantum-Si Incorporated - Ordinary Shares - Class A | Director | 230.5 K | - |
| 2021 | Elutia Inc - Ordinary Shares - Class A | Chairman of the Board | 158.5 K | 718.1 % |
| 2021 | Nyxoah SA | Independent Director | 30 K | - |
| 2020 | Oramed Pharmaceuticals, Inc | Chairman of the Board | 75.5 K | 69.1 % |
| 2020 | Elutia Inc - Ordinary Shares - Class A | Chairman of the Board | 19.4 K | - |
| 2020 | Quantum-Si Incorporated - Ordinary Shares - Class A | Director | - | - |
| 2020 | Nyxoah SA | Independent Director | - | - |
| 2019 | Oramed Pharmaceuticals, Inc | Chairman of the Board | 44.6 K | 123.2 % |
| 2019 | Ocugen Inc | - | 24.4 K | -76.4 % |
| 2019 | Ocugen Inc | Independent Director | - | - |
| 2019 | Elutia Inc - Ordinary Shares - Class A | Chairman of the Board | - | - |
| 2018 | Ocugen Inc | Independent Director | 103.4 K | 41.4 % |
| 2018 | Oramed Pharmaceuticals, Inc | Chairman of the Board | 20 K | -94.1 % |
| 2017 | Oramed Pharmaceuticals, Inc | Chairman of the Board | 336.4 K | - |
| 2017 | Ocugen Inc | Independent Director | 73.2 K | 25.5 % |
| 2016 | Ocugen Inc | Independent Director | 58.3 K | -52.9 % |
| 2016 | Oramed Pharmaceuticals, Inc | Chairman of the Board | - | - |
| 2015 | Ocugen Inc | Independent Director | 123.7 K | 2756.1 % |
| 2015 | Oramed Pharmaceuticals, Inc | Director | - | - |
| 2014 | Ocugen Inc | Independent Director | 4.3 K | -51.8 % |
| 2013 | Ocugen Inc | Independent Director | 9.0 K | - |